| (S)-Lansoprazole |
|
|
|
98.90% |
| (2E)-OBAA |
|
|
|
|
| (E/Z)-BML264 |
|
|
|
99.63% |
| (R)-Bromoenol lactone |
|
|
|
|
| (R)-Bromoenol lactone-d7 |
|
|
|
|
| (S)-Albuterol hydrochloride |
|
|
|
|
| (S)-Bromoenol lactone |
|
|
|
99.1% |
| (S)-Albuterol |
|
|
|
|
| (Z)-Oleyloxyethyl phosphorylcholine |
|
|
|
98.0% |
| (±)-Armepavine hydrochloride |
|
|
|
|
| 1,2-Bis(heptanoylthio)-sn-glycero-3-PG sodium |
|
|
|
|
| 1-Linoleoyl Glycerol |
|
|
|
99.52% |
| 1-Linoleoyl Glycerol-d5 |
|
|
|
|
| 1-Myristoyl-2-Linoleoyl-sn-glycero-3-PC |
|
|
|
|
| 1-Naphthaleneacetic acid |
|
|
|
99.65% |
| 1-Naphthaleneacetic acid potassium salt |
|
|
|
99.64% |
| 2-(E-2-decenoylamino)ethyl 2-(cyclohexylethyl) sulfide |
|
|
|
|
| 2-Methoxybenzoic acid |
|
|
|
99.86% |
| 2-Methoxybenzoic acid-13C6 |
|
|
|
|
| 2-Methoxybenzoic acid-d3 |
|
|
|
|
| 3-Nitrocoumarin |
|
|
|
100.0% |
| 5-Bromo-4-chloro-3-indoxyl myo-inositol-1-phosphate ammonium |
|
|
|
|
| FIPI |
|
|
|
98.00% |
| 7,7-Dimethyl-(5Z,8Z)-eicosadienoic acid |
|
|
|
|
| 7-Hydroxycoumarinyl arachidonate |
|
|
|
99.19% |
| 7-Hydroxycoumarinyl-γ-linolenate |
|
|
|
|
| A3373 |
|
|
|
99.57% |
| A4333 |
|
|
|
|
| AA26-9 |
|
|
|
99.83% |
| AACOCF3 |
|
|
|
99.89% |
| ABC47 |
|
|
|
99.80% |
| AGN-190383 |
|
|
|
|
| AK106-001616 |
|
|
|
|
| Alminoprofen |
|
|
|
99.91% |
| ARC39 |
|
|
|
98.5% |
| ARF1 (2-17) |
|
|
|
|
| ARN19874 |
|
|
|
99.54% |
| ASM-IN-1 |
|
|
|
98.65% |
| ASM-IN-2 |
|
|
|
|
| ASM-IN-3 |
|
|
|
|
| Atg4B-IN-2 |
|
|
|
98.03% |
| Avicin G |
|
|
|
|
| AVX001 |
|
|
|
|
| AX048 |
|
|
|
|
| AZD2716 |
|
|
|
99.9% |
| BAPTA |
|
|
|
98.10% |
| BAPTA tetracesium |
|
|
|
|
| BAPTA tetrasodium |
|
|
|
99.70% |
| BAPTA tetrapotassium |
|
|
|
99.42% |
| BAY-163 |
|
|
|
|
| Benzylideneacetone |
|
|
|
99.66% |
| BHPI |
|
|
|
98.0% |
| BML-280 |
|
|
|
99.64% |
| BMS-188184 |
|
|
|
|
| BMS-229724 |
|
|
|
|
| BRI-50460 |
|
|
|
99.62% |
| Brinazarone |
|
|
|
|
| Bromoenol lactone |
|
|
|
99.59% |
| C10 Bisphosphonate |
|
|
|
98.87% |
| C12 NBD Sphingomyelin |
|
|
|
99.0% |
| Cambinol |
|
|
|
99.89% |
| CAY10502 |
|
|
|
98.72% |
| CAY10590 |
|
|
|
98.0% |
| CAY10594 |
|
|
|
98.64% |
| CAY10650 |
|
|
|
98.0% |
| CAY10650 (Standard) |
|
|
|
|
| CCT129957 |
|
|
|
99.16% |
| CDIBA |
|
|
|
|
| CGP-35949 sodium |
|
|
|
|
| Chlorogentisylquinone |
|
|
|
|
| Cinatrin A |
|
|
|
|
| Cinatrin B |
|
|
|
|
| Cinatrin C1 |
|
|
|
|
| Cinatrin C2 |
|
|
|
|
| Cinatrin C3 |
|
|
|
|
| Compound 48/80 |
|
|
|
99.98% |
| Compound 48/80 (trimer) |
|
|
|
95.0% |
| Compound 48/80 trihydrochloride |
|
|
|
99.83% |
| cPLA2α-IN-2 |
|
|
|
|
| cPLA2α-IN-derivative 1 |
|
|
|
|
| D-Erythro-dihydrosphingosine |
|
|
|
98.0% |
| D-Erythro-dihydrosphingosine-d7 |
|
|
|
99.0% |
| D-myo-Inositol 1,4,5-trisphosphate sodium salt |
|
|
|
|
| D609 |
|
|
|
98.0% |
| Darapladib analog-1 |
|
|
|
|
| DL-erythro-Dihydrosphingosine |
|
|
|
98% |
| DPPI-4,5-P2 ammonium |
|
|
|
|
| DPTIP |
|
|
|
99.68% |
| DPTIP hydrochloride |
|
|
|
|
| DPTIP-prodrug 18 |
|
|
|
|
| DS07551382 |
|
|
|
|
| DS55980254 |
|
|
|
99.25% |
| DS68591889 |
|
|
|
99.18% |
| EA4 |
|
|
|
98.75% |
| Ecopladib |
|
|
|
|
| Efipladib |
|
|
|
|
| FAAH/cPLA2α-IN-1 |
|
|
|
|
| FIPI hydrochloride |
|
|
|
|
| FKGK11 |
|
|
|
|
| FKGK18 |
|
|
|
99.9% |
| Folipastatin |
|
|
|
|
| Fuzapladib |
|
|
|
98.75% |
| Fuzapladib calcium |
|
|
|
|
| Fuzapladib potassium |
|
|
|
|
| Fuzapladib sodium |
|
|
|
99.61% |
| Giripladib |
|
|
|
99.68% |
| GK187 |
|
|
|
98.0% |
| GK470 |
|
|
|
|
| GK563 |
|
|
|
|
| Goxalapladib |
|
|
|
|
| GSK2647544 |
|
|
|
99.50% |
| GW4869 |
|
|
|
95.12% |
| Halopemide |
|
|
|
99.65% |
| Heptanoyl thio-PC |
|
|
|
|
| hnps-PLA-IN-1 |
|
|
|
|
| HpFabZ-IN-1 |
|
|
|
|
| Ikshusterol 3-O-glucoside |
|
|
|
|
| Isosalvianolic acid C |
|
|
|
|
| KARI 201 |
|
|
|
|
| KARI 201 hydrochloride |
|
|
|
99.94% |
| KH064 |
|
|
|
99.84% |
| LCL521 |
|
|
|
98.53% |
| LCL521 dihydrochloride |
|
|
|
98.12% |
| LEI-401 |
|
|
|
99.73% |
| LEI110 |
|
|
|
99.72% |
| LFHP-1c |
|
|
|
98.01% |
| Lp-PLA2-IN-1 |
|
|
|
99.30% |
| Lp-PLA2-IN-10 |
|
|
|
|
| Lp-PLA2-IN-11 |
|
|
|
|
| Lp-PLA2-IN-12 |
|
|
|
|
| Lp-PLA2-IN-13 |
|
|
|
99.87% |
| Lp-PLA2-IN-14 |
|
|
|
|
| Lp-PLA2-IN-15 |
|
|
|
99.13% |
| Lp-PLA2-IN-16 |
|
|
|
|
| Lp-PLA2-IN-17 |
|
|
|
|
| Lp-PLA2-IN-2 |
|
|
|
|
| Lp-PLA2-IN-3 |
|
|
|
99.94% |
| Lp-PLA2-IN-4 |
|
|
|
|
| Lp-PLA2-IN-5 |
|
|
|
|
| Lp-PLA2-IN-6 |
|
|
|
|
| Lp-PLA2-IN-9 |
|
|
|
|
| Luffariellolide |
|
|
|
|
| LY 178002 |
|
|
|
99.60% |
| LY-311727 |
|
|
|
98.61% |
| LY256548 |
|
|
|
|
| LY433771 |
|
|
|
99.8% |
| Ly93 |
|
|
|
99.85% |
| Lyso-PAF C-16 |
|
|
|
99.5% |
| Lyso-PAF C-16-d4 |
|
|
|
99.0% |
| Lyso-sulfatide (bovine) ammonium |
|
|
|
|
| Lysophospholipase, Vibrio sp. |
|
|
|
|
| m-3M3FBS |
|
|
|
99.99% |
| M119 |
|
|
|
|
| MAFP |
|
|
|
98.6% |
| Malabaricone C |
|
|
|
99.46% |
| Manoalogue |
|
|
|
|
| Me-Indoxam |
|
|
|
|
| Melittin free acid |
|
|
|
|
| Methyl γ-linolenyl fluorophosphonate |
|
|
|
|
| MJ33 |
|
|
|
|
| MJ33 lithium salt |
|
|
|
99.0% |
| MJ33-OH |
|
|
|
|
| MJ33-OH lithium |
|
|
|
|
| ML-211 |
|
|
|
99.42% |
| ML-298 |
|
|
|
96.94% |
| ML114 |
|
|
|
|
| ML256 |
|
|
|
|
| ML299 |
|
|
|
99.46% |
| ML348 |
|
|
|
99.97% |
| ML349 |
|
|
|
98.90% |
| ML378 |
|
|
|
|
| N-Palmitoyl-l-leucine |
|
|
|
99.98% |
| N-Stearoylsphingomyelin |
|
|
|
98.60% |
| NDs-IN-1 |
|
|
|
|
| Neomycin |
|
|
|
|
| nSMase2-IN-1 |
|
|
|
|
| OBAA |
|
|
|
99.31% |
| Ochnaflavone |
|
|
|
98.30% |
| ONO-RS-082 |
|
|
|
99.31% |
| OXA(17-33) |
|
|
|
97.48% |
| P11 |
|
|
|
99.69% |
| PACOCF3 |
|
|
|
98.0% |
| Parameritannin A-1 |
|
|
|
|
| PC(O-16:0/18:2(9Z,12Z)) |
|
|
|
|
| PDDC |
|
|
|
99.97% |
| Phosphatidylinositol 4,5-bisphosphate |
|
|
|
|
| Phospholipase A2, Porcine |
|
|
|
|
| Phospholipase A2, Streptomyces violaceoruber |
|
|
|
|
| PLA2-IN-1 |
|
|
|
|
| PLC thio-PIP2 trisodium |
|
|
|
|
| PLC-β-IN-1 |
|
|
|
|
| PLD-IN-1 |
|
|
|
99.18% |
| Plipastatin A1 |
|
|
|
|
| Plipastatin B1 |
|
|
|
|
| PSB 0474 |
|
|
|
|
| pTH (1-34) amide (human) |
|
|
|
99.78% |
| Pyrrophenone |
|
|
|
99.60% |
| (R)-N-(1-Hydroxypropan-2-yl)palmitamide |
|
|
|
92.09% |
| Ranakinin |
|
|
|
|
| RHC 80267 |
|
|
|
99.41% |
| Rilapladib |
|
|
|
99.44% |
| RK-682 |
|
|
|
|
| RK-682 hemicalcium |
|
|
|
|
| Ro 23-9358 |
|
|
|
|
| Ro 31-4639 |
|
|
|
|
| ROC-0929 |
|
|
|
99.62% |
| SB-435495 |
|
|
|
99.71% |
| SB-435495 ditartrate |
|
|
|
|
| SB-435495 hydrochloride |
|
|
|
|
| SHP1-IN-2 |
|
|
|
|
| SM (d18:1/15:0) |
|
|
|
|
| SMase-IN-1 |
|
|
|
|
| SMases D-IN-1 |
|
|
|
|
| SMS1-IN-1 |
|
|
|
98.38% |
| SMS2-IN-1 |
|
|
|
98.00% |
| SMS2-IN-2 |
|
|
|
98.0% |
| SMS2-IN-3 |
|
|
|
|
| Soy PE |
|
|
|
98% |
| Sphingolactone-24 |
|
|
|
|
| SPK-601 |
|
|
|
99.60% |
| sPLA2 inhibitor 2 |
|
|
|
|
| sPLA2 inhibitor 3 |
|
|
|
|
| sPLA2-IIA Inhibitor |
|
|
|
|
| sPLA2-X Inhibitor 31 |
|
|
|
|
| ST271 |
|
|
|
98.00% |
| Thioetheramide-PC |
|
|
|
98% |
| Tris(2,4-di-tert-butylphenyl)phosphate |
|
|
|
99.81% |
| U 84569 |
|
|
|
|
| U-73122 |
|
|
|
98.28% |
| U-73343 |
|
|
|
99.43% |
| Varespladib methyl |
|
|
|
99.64% |
| VI-60 |
|
|
|
|
| Vinaxanthone |
|
|
|
98.15% |
| VU 0364739 hydrochloride |
|
|
|
|
| VU0155056 |
|
|
|
|
| VU0155069 |
|
|
|
98.55% |
| VU0155069 hydrochloride |
|
|
|
|
| VU0359595 |
|
|
|
98.06% |
| VU0364739 |
|
|
|
99.16% |
| VU533 |
|
|
|
99.84% |
| WAY-196025 |
|
|
|
|
| WH-15 |
|
|
|
99.51% |
| YM-26734 |
|
|
|
99.7% |
| ZPL-5212372 |
|
|
|
|
| Magnesium sulfate heptahydrate, meets analytical specification of Ph. Eur. BP USP FCC |
|
|
|
|
| Magnesium sulfate heptahydrate, United States Pharmacopeia (USP) Reference Standard |
|
|
|
|
| Protizinic acid |
|
|
|
|
| Tanshinone I |
|
|
|
98.83% |
| Difluprednate-d3-1 |
|
|
|
|
| Difluprednate |
|
|
|
99.63% |
| trans-Benzylideneacetone |
|
|
|
99.87% |
| Varespladib-d7 |
|
|
|
|
| Varespladib |
|
|
|
99.74% |
| Varespladib sodium |
|
|
|
98.83% |
| Lansoprazole |
|
|
|
99.92% |
| Lansoprazole sodium |
|
|
|
98.80% |
| Manumycin A |
|
|
|
98.30% |
| Rapanone |
|
|
|
99.93% |
| Choline tosylate |
|
|
|
99.90% |
| Neomycin sulfate |
|
|
|
99.92% |
| Magnesium sulfate |
|
|
|
99.03% |
| Magnesium sulfate, for cell culture |
|
|
|
99.0% |
| Phospholipase D, Streptomyces chromofuscus |
|
|
|
|
| Phospholipase A2 |
|
|
|
|
| Phospholipase A2, Crotalus adamanteus Venom |
|
|
|
|
| Phospholipase C |
|
|
|
|
| Phospholipase D, cabbage |
|
|
|
|
| Phospholipase D, peanut |
|
|
|
|
| Melittin TFA |
|
|
|
99.85% |
| Melittin |
|
|
|
99.55% |
| Darapladib |
|
|
|
99.92% |
| Sphingomyelin phosphodiesterase, Streptomyces sp. |
|
|
|
|
| Rhamnetin |
|
|
|
99.18% |